CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Grant or award · Restricted Stock Units | +13,823 | 13,823 | ||
| 2022-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Option exercise · Restricted Stock Units | −3,456 | 10,367 | ||
| 2022-02-14 | Pavesio Alessandra SVP & Chief Science Officer | Sale | −433 | $11.99 | $5K | 119,830 |
| 2022-02-14 | D'Adamio Anthony SVP & General Counsel | Sale | −1,294 | $11.99 | $16K | 18,672 |
| 2022-02-14 | Anglum Gregory O. SVP & CFO | Sale | −1,294 | $11.99 | $16K | 55,013 |
| 2022-02-14 | Nosenzo John Chief Commercial Officer | Sale | −534 | $11.99 | $6K | 43,370 |
| 2022-02-11 | Pavesio Alessandra SVP & Chief Science Officer | Option exercise | +1,470 | 120,263 | ||
| 2022-02-11 | Pavesio Alessandra SVP & Chief Science Officer | Option exercise · Restricted Stock Units | −1,470 | 0 | ||
| 2022-02-11 | NEELS GUIDO J Director | Option exercise | +9,000 | 9,000 | ||
| 2022-02-11 | NEELS GUIDO J Director | Option exercise · Restricted Stock Units | −9,000 | 0 | ||
| 2022-02-11 | NOHRA GUY P Director | Option exercise | +9,000 | 9,000 | ||
| 2022-02-11 | NOHRA GUY P Director | Option exercise · Restricted Stock Units | −9,000 | 0 | ||
| 2022-02-11 | D'Adamio Anthony SVP & General Counsel | Option exercise | +4,400 | 19,966 | ||
| 2022-02-11 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −4,400 | 0 | ||
| 2022-02-11 | Anglum Gregory O. SVP & CFO | Option exercise | +4,400 | 56,307 | ||
| 2022-02-11 | Anglum Gregory O. SVP & CFO | Option exercise · Restricted Stock Units | −4,400 | 0 | ||
| 2022-02-11 | Nosenzo John Chief Commercial Officer | Option exercise | +1,470 | 43,904 | ||
| 2022-02-11 | Nosenzo John Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,470 | 0 | ||
| 2022-02-11 | Cowdy Philip G. Director | Option exercise | +9,000 | 9,000 | ||
| 2022-02-11 | Cowdy Philip G. Director | Option exercise · Restricted Stock Units | −9,000 | 0 |
Page 20 of 22 · 437 trades